Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,075 | 287 | 75.6% |
| Travel and Lodging | $1,811 | 8 | 22.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125.00 | 1 | 1.6% |
| Education | $23.16 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,632 | 22 | $0 (2023) |
| Bard Peripheral Vascular, Inc. | $1,376 | 20 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $475.33 | 19 | $0 (2024) |
| Amgen Inc. | $468.53 | 22 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $426.48 | 26 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $392.28 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $383.21 | 24 | $0 (2024) |
| Relypsa, Inc. | $299.52 | 23 | $0 (2020) |
| Vifor Pharma, Inc. | $288.06 | 15 | $0 (2024) |
| Avenu Medical Inc. | $255.85 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $921.72 | 42 | Vifor Pharma, Inc. ($104.95) |
| 2023 | $636.42 | 32 | Bayer Healthcare Pharmaceuticals Inc. ($104.26) |
| 2022 | $2,565 | 64 | Medtronic, Inc. ($1,565) |
| 2021 | $533.36 | 35 | Vifor Pharma, Inc. ($88.20) |
| 2020 | $1,372 | 30 | Bard Peripheral Vascular, Inc. ($861.42) |
| 2019 | $854.03 | 31 | BARD PERIPHERAL VASCULAR, INC. ($406.03) |
| 2018 | $659.27 | 41 | Relypsa, Inc. ($93.70) |
| 2017 | $492.46 | 28 | Amgen Inc. ($166.62) |
All Payment Transactions
303 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Immunology | ||||||
| 12/13/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: NEPHROLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: Immunology | ||||||
| 12/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Nephrology | ||||||
| 12/02/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Hyperkalemia | ||||||
| 11/13/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: NEPHROLOGY | ||||||
| 11/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Nephrology | ||||||
| 10/30/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $38.51 | General |
| Category: Catheter Lock Solution | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: NEPHROLOGY | ||||||
| 10/07/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.41 | General |
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: NEPHROLOGY | ||||||
| 09/16/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Nephrology | ||||||
| 08/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Cardio-renal | ||||||
| 08/14/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: NEPHROLOGY | ||||||
| 08/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Hyperkalemia | ||||||
| 07/30/2024 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Wound Care | ||||||
| 07/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardio-renal | ||||||
| 07/12/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Nephrology | ||||||
| 07/09/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Hyperkalemia | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.20 | General |
| 06/24/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.41 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 913 | 1,776 | $584,680 | $204,554 |
| 2022 | 23 | 975 | 1,896 | $600,479 | $216,767 |
| 2021 | 29 | 1,229 | 5,155 | $1.0M | $313,601 |
| 2020 | 31 | 1,478 | 8,592 | $1.5M | $434,728 |
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Office | 2023 | 36 | 45 | $148,297 | $38,368 | 25.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 185 | 628 | $59,032 | $36,771 | 62.3% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 23 | 118 | $53,100 | $25,514 | 48.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 12 | 57 | $25,650 | $15,013 | 58.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 251 | $25,593 | $13,343 | 52.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 86 | 89 | $23,140 | $11,393 | 49.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 52 | 175 | $32,373 | $9,178 | 28.4% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Office | 2023 | 14 | 16 | $30,864 | $7,940 | 25.7% |
| 36581 | Replacement of tunneled central venous tube | Office | 2023 | 16 | 17 | $36,275 | $7,889 | 21.7% |
| 36215 | Insertion of tube into chest or arm artery, each first order branch | Office | 2023 | 16 | 18 | $50,760 | $6,633 | 13.1% |
| 36907 | Balloon dilation of dialysis segment with review by radiologist | Office | 2023 | 13 | 15 | $24,255 | $6,337 | 26.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 11 | 22 | $9,900 | $4,812 | 48.6% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 19 | 67 | $12,395 | $4,254 | 34.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $6,525 | $4,249 | 65.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 34 | $6,868 | $3,314 | 48.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 47 | $5,875 | $2,746 | 46.7% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Office | 2023 | 24 | 27 | $7,410 | $1,826 | 24.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 31 | 40 | $5,440 | $1,402 | 25.8% |
| 36589 | Removal of tunneled central venous tube | Office | 2023 | 14 | 14 | $6,508 | $1,212 | 18.6% |
| 93986 | Complete ultrasound of artery and vein blood flow pre-op assessment on side of body for hemodialysis access | Office | 2023 | 13 | 13 | $5,208 | $1,188 | 22.8% |
| 75710 | Review by radiologist of arm or leg artery image | Office | 2023 | 18 | 20 | $8,940 | $1,098 | 12.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 34 | 34 | $272.00 | $74.80 | 27.5% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Office | 2022 | 43 | 47 | $160,035 | $41,010 | 25.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 213 | 697 | $65,518 | $37,621 | 57.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 19 | 117 | $52,650 | $24,506 | 46.5% |
About Dr. John Clark, M.D
Dr. John Clark, M.D is a Internal Medicine healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578631784.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Clark, M.D has received a total of $8,034 in payments from pharmaceutical and medical device companies, with $921.72 received in 2024. These payments were reported across 303 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,075).
As a Medicare-enrolled provider, Clark has provided services to 4,595 Medicare beneficiaries, totaling 17,419 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Huntsville, AL
- Active Since 12/04/2006
- Last Updated 03/21/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578631784
Products in Payments
- VENASEAL (Device) $1,506
- Veltassa (Drug) $587.58
- Kerendia (Drug) $475.33
- LOKELMA (Drug) $295.91
- Ellipsys (Device) $291.78
- WavelinQ (Device) $286.32
- RAYALDEE (Drug) $283.62
- JYNARQUE (Drug) $232.90
- Parsabiv (Drug) $215.49
- Velphoro (Drug) $193.01
- Parsabiv (Biological) $173.94
- TARPEYO (Drug) $162.44
- SAMSCA (Drug) $159.38
- JARDIANCE (Drug) $151.86
- Rayaldee (Drug) $142.86
- NATPARA (PARATHYROID HORMONE) (Drug) $141.71
- Auryxia (Drug) $138.53
- Rituxan (Biological) $104.70
- BENLYSTA (Biological) $99.35
- LUPKYNIS (Drug) $91.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntsville
Dr. James Roy, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $849,153
Dr. Gaurav Aggarwala, M.d, M.D
Internal Medicine — Payments: $115,539
Dr. Kaushik Jain, Do, DO
Internal Medicine — Payments: $61,725
Jeffery Allison, M.d, M.D
Internal Medicine — Payments: $33,217
Ehab El-Bahesh, M.d, M.D
Internal Medicine — Payments: $31,265
Dr. Kun Chen, Md, Phd, MD, PHD
Internal Medicine — Payments: $24,543